Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App

Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...

New group of potential diabetes drugs with fewer side effects can reprogram insulin-resistant cells to be healthier

Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps Institute have ...

Best Workload Management Tools in 2026 for Smarter Resource Allocation

Compare and discover the best workload management tools like ClickUp and Teamwork.com for balancing team capacity and tracking utilization.

Should Abbott’s AI-Powered Libre Assist Shift Its Diabetes Platform Strategy Narrative for ABT Investors?

In early January 2026, Abbott Laboratories unveiled Libre Assist, an AI-powered feature within its Libre app that helps U.S.